Search
From Date :
To Date :
Serivce :
Query :
Keywords :
 ( Seprate With , )
First non-human primate study showing promise of gene therapy for stroke repair
Stroke is a leading cause of death and severe long-term disability with limited treatment available. A research team led by Professor Gong Chen at Jinan University, Guangzhou, China recently reported the first non-human primate study demonstrating successful in vivo neural regeneration from brain internal glial cells for stroke repair. This work was published on Frontiers in Cell and Developmental Biology.
Immune-boosting drug therapy that gives years of extra life to patients with incurable bladder cancer
Thousands of Britons with incurable bladder cancer will be offered fresh hope thanks to an immune-boosting drug therapy that gives years of extra life.
Meditation-relaxation therapy may offer escape from the terror of sleep paralysis
Sleep paralysis — a condition thought to explain a number of mysterious experiences including alleged cases of alien abduction and demonic night-time visits — could be treated using a technique of meditation-relaxation, suggested a pilot study.
Sugar-based signature identifies T cells where HIV hides despite antiretroviral therapy
Scientists at The Wistar Institute may have discovered a new way of identifying and targeting hidden HIV viral reservoirs during treatment with antiretroviral therapy (ART). These findings were published in Cell Reports and may have translational implications for improving the long-term care of HIV positive people.
Researchers advance new therapy with potential benefit  for underserved patients with lung and ovarian cancers
In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1), researchers from The University of Texas MD Anderson Cancer Center's Therapeutics Discovery division and Ipsen Biopharmaceuticals reported the preclinical discovery and early-stage clinical development of this novel drug. IPN60090, now under investigation in a Phase I trial, may hold benefit for certain patients with lung and ovarian cancers.
Diabetes drug reduces complications of long-term steroid therapy
A drug used to treat type 2 diabetes could offer a simple and cheap solution to reduce dangerous side effects of steroid treatment, new research from Queen Mary University of London suggests.
Pointless work meetings 'really a form of therapy'
Meetings at work should be seen as a form of "therapy" rather than about decision-making, said researchers.
Peanut-allergy therapy 'protection not a cure'
Treating peanut allergy with regular exposure to small amounts of the food is effective — but only if a patient stays on the therapy, a study suggests.
Radical light and sound wave therapy could slow Alzheimer's
Doctors in the US have launched a clinical trial to see whether exposure to flickering lights and low frequency sounds can slow the progression of Alzheimer’s disease.
How dietary change might boost cancer therapy
In a recent study, mice that ate a diet with reduced levels of a particular amino acid responded better to cancer treatments.
Insomnia sufferers can benefit from therapy
Forget counting sheep and drinking warm milk, an effective way to tackle chronic insomnia is cognitive behavioural therapy (CBT), researchers have confirmed.
'Unique' cells could open up new avenues for ALS therapy
Amyotrophic lateral sclerosis, or ALS, is a progressive neurodegenerative disease that leads to the death of nerve cells that control movement, leaving people unable to move and, eventually, to breathe.
Coping strategy therapy for family dementia carers works long-term
A program of therapy and coping strategies for people who care for family members with dementia successfully improves the carers' mental health for at least a six-year follow-up, finds a UCL study.
Targeted therapy combination improves  survival in patients with advanced bowel cancer
New data have shown for the first time that a combination of targeted therapies can improve survival in patients with advanced bowel cancer. Results of the BEACON CRC Phase III trial have shown that triple therapy targeting BRAF mutations in progressive metastatic colorectal tumors significantly improved overall survival and objective response compared to standard care.

Page Generated in 0/2008 sec